Chronic tempol treatment attenuates the renal hemodynamic effects induced by a heme oxygenase inhibitor in streptozotocin diabetic rats

被引:25
|
作者
Rodriguez, Francisca [1 ]
Lopez, Bernardo [1 ]
Perez, Cayetano [1 ]
Fenoy, Francisco J. [1 ]
Hernandez, Isabel [1 ]
Stec, David E. [2 ]
Volti, Giovanni Li [3 ]
Salom, Miguel G. [1 ]
机构
[1] Univ Murcia, Murcia Sch Med, Dept Physiol, E-30100 Murcia, Spain
[2] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Ctr Excellence Cardiovasc Renal Res, Jackson, MS 39216 USA
[3] Univ Catania, Fac Pharm, Biochem Sect, Dept Drug Sci, Catania, Italy
关键词
oxidative stress; nitrotyrosine; type-1; diabetes; NITRIC-OXIDE SYNTHESIS; CARBON-MONOXIDE; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; AFFERENT ARTERIOLES; KIDNEY; INCREASE; INDUCTION; RESTORES; MELLITUS;
D O I
10.1152/ajpregu.00847.2010
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Rodriguez F, Lopez B, Perez C, Fenoy FJ, Hernandez I, Stec DE, Li Volti G, Salom MG. Chronic tempol treatment attenuates the renal hemodynamic effects induced by a heme oxygenase inhibitor in streptozotocin diabetic rats. Am J Physiol Regul Integr Comp Physiol 301: R1540 -R1548, 2011. First published August 17, 2011; doi:10.1152/ajpregu.00847.2010.-Heme oxygenase-1 (HO-1) is induced by oxidative stress and plays an important role in protecting the kidney from oxidant-mediated damage in the streptozotocin (STZ) rat model of type-1 diabetes mellitus (DM-1). HO-derived metabolites, presumably carbon monoxide (CO), mediate vasodilatory influences in the renal circulation, particularly in conditions linked to elevated HO-1 protein expression or diminished nitric oxide (NO) levels. We tested the hypothesis that diabetes increases oxidative stress and induces HO-1 protein expression, which contributes to regulate renal hemodynamics in conditions of low NO bioavailability. Two weeks after the induction of diabetes with STZ (65 mg/kg iv), Sprague-Dawley rats exhibited higher renal HO-1 protein expression, hyperglycemia, and elevated renal nitrotyrosine levels than control normoglycemic animals. In anesthetized diabetic rats, renal vascular resistance (RVR) was increased, and in vivo cortical NO levels were reduced (P < 0.05) compared with control animals. Acute administration of the HO inhibitor Stannous mesoporphyrin (SnMP; 40 mu mol/kg iv) did not alter renal hemodynamics in control rats, but greatly decreased glomerular filtration rate and renal blood flow, markedly increasing RVR in hyperglycemic diabetic rats. Chronic oral treatment with the SOD mimetic tempol prevented the elevation of nitrotyrosine, the HO-1 protein induction, and the increases in RVR induced by SnMP in the diabetic group, without altering basal NO concentrations or RVR. Increasing concentrations of a CO donor (CO-releasing molecule-A1) on pressurized renal interlobar arteries elicited a comparable relaxation in vessels taken from control or diabetic animals. These results suggest that oxidative stress-induced HO-1 exerts vasodilatory actions that partially maintain renal hemodynamics in uncontrolled DM-1.
引用
收藏
页码:R1540 / R1548
页数:9
相关论文
共 50 条
  • [21] Inhibition of estradiol synthesis attenuates diabetic renal disease in male streptozotocin (STZ)-induced diabetic rats
    Manigrasso, Michaele B.
    Marbury, David C.
    Sawyer, R. Taylor
    Flynn, Elizabeth R.
    Maric, Christine
    FASEB JOURNAL, 2010, 24
  • [22] Catechin attenuates diabetic autonomic neuropathy in streptozotocin induced diabetic rats
    Addepalli, Veeranjaneyulu
    Suryavanshi, Sachin V.
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 108 : 1517 - 1523
  • [23] Taxifolin attenuates diabetic nephropathy in streptozotocin-induced diabetic rats
    Zhao, Yanling
    Huang, Wenwen
    Wang, Jiali
    Chen, Yan
    Huang, Wen
    Zhu, Yonglin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (04): : 1205 - 1210
  • [24] Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats
    Liu, Wei Jing
    Xie, Shu Hua
    Liu, Yu Ning
    Kim, Won
    Jin, Heung Yong
    Park, Sung Kwang
    Shao, Yi Ming
    Park, Tae Sun
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 340 (02): : 248 - 255
  • [25] ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats
    Coppey, LJ
    Davidson, EP
    Rinehart, TW
    Gellett, JS
    Oltman, CL
    Lund, DD
    Yorek, MA
    DIABETES, 2006, 55 (02) : 341 - 348
  • [26] ACUTE AND CHRONIC EFFECTS OF THROMBOXANE A(2) INHIBITION ON THE RENAL HEMODYNAMICS IN STREPTOZOTOCIN-INDUCED DIABETIC RATS
    URIU, K
    KAIZU, K
    HASHIMOTO, O
    KOMINE, N
    ETOH, S
    KIDNEY INTERNATIONAL, 1994, 45 (03) : 794 - 802
  • [27] Inhibition of estradiol synthesis attenuates renal injury in male streptozotocin-induced diabetic rats
    Manigrasso, Michaele B.
    Sawyer, R. Taylor
    Marbury, David C.
    Flynn, Elizabeth R.
    Maric, Christine
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2011, 301 (03) : F634 - F640
  • [28] Renoprotective effects of dual treatment with dihydrotestosterone and an aromatase inhibitor in male streptozotocin (STZ)-induced diabetic rats
    Manigrasso, Michaele B.
    Sawyer, R. Taylor
    Flynn, Elizabeth R.
    Maric, Christine
    FASEB JOURNAL, 2011, 25
  • [29] Induction of heme oxygenase-1 ameliorates vascular dysfunction in streptozotocin-induced type 2 diabetic rats
    Wang, Yang
    Ying, Lei
    Chen, Ying-ying
    Shen, Yue-liang
    Guo, Rui
    Jin, Ke-ke
    Wang, Liang-xing
    VASCULAR PHARMACOLOGY, 2014, 61 (01) : 16 - 24
  • [30] Antioxidant mixture attenuates renal purinergic signalling alterations in streptozotocin-induced diabetic rats
    Chtourou, Y.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S69 - S69